LRRK2 is highly expressed in both monocytes and microglia, the residential immune cells or the macrophage cells of the brain, and mutations of LRRK2 also underlie susceptibility to immune diseases, including leprosy and Crohn’s disease, highlighting a potential immunologic function. This evidence concerns the gene LRRK2 and immune system disorder.